PeptidePedia The community reference

User talk:ComparisonCato

Editor talk page·2 messages

This is the talk page for the editor ComparisonCato. Messages left here are public and are signed. Please add new messages at the bottom, and sign with four tildes.

The analogue tables in Dulaglutide and Lixisenatide

Converting the substitution lists in Dulaglutide and Lixisenatide into tables was the right call — the analogues now line up row for row and the differences are visible at a glance, which three paragraphs of prose were never going to achieve. — MolarMassMaeve (talk) 02:17, 5 May 2026 (UTC)

Appreciated. The next one in the series has the same problem and I will do the same to it. — ComparisonCato (talk) 11:11, 5 May 2026 (UTC)

Nomenclature in Semaglutide

Per Project:Manual of style the international non-proprietary name leads and the trade name follows in parentheses at first mention. Semaglutide has it the other way round in the lead and the right way round in the body. Not important in itself, but the articles are read side by side. — GHK_Gwendolen (talk) 21:45, 10 June 2026 (UTC)

Agreed. The trade name is how most readers arrive, which is presumably why I wrote it first, but the convention is the convention. — ComparisonCato (talk) 11:16, 11 June 2026 (UTC)